Profile
Sector:
HealthcareIndustry:
Medical DevicesCountry:
United StatesIPO:
22 April 2021Website:
http://www.neuropace.comNext earnings report:
08 August 2024Last dividends:
N/ANext dividends:
N/APrice
after hours | Mon, 01 Jul 2024 20:03:21 GMTDividend
Analysts recommendations
Institutional Ownership
NPCE Latest News
NeuroPace, Inc. (NASDAQ: NPCE) Q1 2024 Earnings Conference Call on May 8, 2024 at 4:30 PM ET featuring company participants Jeremy Feffer, Joel Becker, and Rebecca Kuhn. Conference call participants include Mike Kratky, Frank Takkinen, Vik Chopra, Ross Osborn, Michael Polark, and Drew Ranieri. Operator welcomes attendees to NeuroPace's First Quarter 2024 Conference Call, which is being recorded.
NeuroPace, Inc. (NASDAQ:NPCE) Q4 2023 Earnings Conference Call March 5, 2024 4:30 PM ET
MOUNTAIN VIEW, Calif., Dec. 19, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced that its management team will present at the 42nd Annual J.P. Morgan Healthcare Conference at 7:30am PT (10:30am ET) on Thursday, January 10, 2024, in San Francisco, CA as well as host investor meetings prior to and during the conference.
NeuroPace, Inc. (NASDAQ:NPCE ) Q3 2023 Earnings Conference Call November 6, 2023 4:30 PM ET Company Participants Irina Ridley - Chief Legal Officer and Head of Investor Relations Joel Becker - Chief Executive Officer Rebecca Kuhn - Chief Financial Officer Conference Call Participants Vik Chopra - Wells Fargo Michael Polark - Wolfe Research Frank Takkinen - Lake Street Capital Markets Operator Ladies and gentlemen, greetings and welcome to the NeuroPace, Inc. Third Quarter 2023 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
MOUNTAIN VIEW, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of people living with epilepsy, today announced it will report financial results for the third quarter of 2023 after market close on Monday November 6, 2023. The company's management will webcast a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
NeuroPace aims to improve the lives of epilepsy patients with its remote monitoring system. The company's RNS system offers personalized and real-time treatments for epilepsy patients. NeuroPace has seen improved commercial traction and increased sales guidance but still faces significant operating losses and cash burn.
NeuroPace, Inc. (NASDAQ:NPCE ) Q2 2023 Earnings Conference Call August 8, 2023 4:30 PM ET Company Participants Irina Ridley - Chief Legal Officer and Head of Investor Relations Joel Becker - Chief Executive Officer Rebecca Kuhn - Chief Financial Officer Conference Call Participants Frank Takkinen - Lake Street Capital Markets Paige Chamberlain - Wolfe Research Operator Good afternoon and welcome to NeuroPace's Second Quarter 2023 Earnings Conference Call. As a reminder, this conference is being recorded.
NeuroPace, Inc. (NASDAQ:NPCE ) Q1 2023 Earnings Conference Call May 4, 2023 4:30 PM ET Company Participants Trip Taylor - Gilmartin Group Michael Favet - President & Chief Executive Officer, NeuroPace, Inc. Rebecca Kuhn - Chief Financial Officer & Vice President, NeuroPace, Inc. Conference Call Participants Rohan - JP Morgan Frank Takkinen - Lake Street Capital Markets Michael Polark - Wolfe Research Operator Good afternoon, and welcome to NeuroPace's First Quarter Earnings Conference Call. At this time, all participants are in a listen-only mode.
What type of business is NeuroPace?
NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and enables clinicians to monitor patients in person and remotely. It sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. The company was incorporated in 1997 and is headquartered in Mountain View, California.
What sector is NeuroPace in?
NeuroPace is in the Healthcare sector
What industry is NeuroPace in?
NeuroPace is in the Medical Devices industry
What country is NeuroPace from?
NeuroPace is headquartered in United States
When did NeuroPace go public?
NeuroPace initial public offering (IPO) was on 22 April 2021
What is NeuroPace website?
https://www.neuropace.com
Is NeuroPace in the S&P 500?
No, NeuroPace is not included in the S&P 500 index
Is NeuroPace in the NASDAQ 100?
No, NeuroPace is not included in the NASDAQ 100 index
Is NeuroPace in the Dow Jones?
No, NeuroPace is not included in the Dow Jones index
When does NeuroPace report earnings?
The next expected earnings date for NeuroPace is 08 August 2024